Global Health Limited — quarter and year ended 31 March 2026
Optional notes: Financial figures are presented in ₹ millions (unless otherwise stated). “Quarter ended 31 March 2026” is a balancing figure between audited full-year and unaudited year-to-date figures up to 31 December 2025.
| S No. | Particulars | Quarter Ended 31 March 2026 (Refer note 11) | Quarter Ended 31 December 2025 (Unaudited) | Quarter Ended 31 March 2025 (Refer note 11) | Year Ended 31 March 2026 (Audited) | Year Ended 31 March 2025 (Audited) |
|---|---|---|---|---|---|---|
| I | Income | |||||
| Revenue from operations | 9,606.29 | 9,401.65 | 8,028.68 | 37,093.78 | 32,041.46 | |
| II | Other income | 358.05 | 246.64 | 256.66 | 1,064.08 | 908.09 |
| Total income | 9,964.34 | 9,648.29 | 8,285.34 | 38,157.86 | 32,949.55 | |
| III | Expenses | |||||
| Cost of materials consumed | 1,886.44 | 2,018.33 | 1,723.75 | 7,858.56 | 7,158.13 | |
| Purchases of stock-in-trade | (0.05) | (5.67) | 58.23 | 19.43 | 403.90 | |
| Changes in inventories of stock-in-trade | – | 5.98 | 32.07 | 46.11 | 26.24 | |
| Employee benefits expense | 2,556.81 | 2,523.00 | 1,854.16 | 9,892.59 | 7,462.91 | |
| Finance costs | 134.64 | 130.80 | 70.99 | 410.85 | 333.91 | |
| Depreciation and amortisation expense | 522.08 | 478.63 | 379.80 | 1,709.07 | 1,496.11 | |
| Retainers and consultants fee | 1,559.40 | 1,510.78 | 1,064.64 | 5,445.32 | 4,038.72 | |
| Other expenses | 1,670.27 | 1,605.58 | 1,343.87 | 6,283.16 | 5,300.20 | |
| Total expenses | 8,329.59 | 8,267.43 | 6,527.51 | 31,665.09 | 26,220.12 | |
| IV | Profit before exceptional items and tax | 1,634.75 | 1,380.86 | 1,757.83 | 6,492.77 | 6,729.43 |
| Exceptional items (refer note 6) | – | 352.00 | 498.96 | (3.77) | 498.96 | |
| V | Profit before tax | 1,634.75 | 1,028.86 | 1,258.87 | 6,496.54 | 6,230.47 |
| VI | Tax expenses | |||||
| Current tax | 326.31 | 247.52 | 361.77 | 1,345.72 | 1,608.65 | |
| Tax pertaining to earlier years | (7.85) | (25.45) | 6.88 | (33.30) | 6.88 | |
| Deferred tax charge/(credit) | 74.98 | 7.72 | (43.90) | 222.11 | (0.34) | |
| VII | Profit after tax | 1,241.31 | 799.07 | 934.12 | 4,962.01 | 4,615.28 |
| VIII | Other comprehensive income | |||||
| (i) Items that will not be reclassified to statement of profit or loss | 47.94 | 6.36 | (30.20) | 46.64 | (12.94) | |
| (ii) Equity instruments through OCI | (1.60) | – | – | (1.60) | – | |
| (iii) Income-tax relating to items that will not be reclassified to statement of profit or loss | (12.07) | (1.60) | 7.60 | (11.74) | 3.26 | |
| Total other comprehensive income | 34.27 | 4.76 | (22.60) | 33.30 | (9.68) | |
| IX | Total comprehensive income | 1,275.58 | 803.83 | 911.52 | 4,995.31 | 4,605.60 |
| X | Paid-up equity share capital (face value of ₹ 2 each) | 537.38 | 537.58 | 537.17 | 537.38 | 537.17 |
| XI | Reserves (other equity) | – | – | – | 39,588.28 | 34,438.91 |
| XII | Earnings per share (face value of ₹ 2 each) (not annualised for the quarters) | |||||
| Basic (₹ per share) | 4.62 | 2.97 | 3.48 | 18.46 | 17.18 | |
| Diluted (₹ per share) | 4.61 | 2.97 | 3.48 | 18.42 | 17.18 |
| Particulars | As at 31 March 2026 (Audited) | As at 31 March 2025 (Audited) |
|---|---|---|
| ASSETS | ||
| Property, plant and equipment | 23,404.48 | 14,663.01 |
| Right-of-use assets | 5,489.10 | 3,896.17 |
| Capital work-in-progress | 1,197.01 | 4,535.46 |
| Intangible assets | 137.85 | 48.55 |
| Intangible assets under development | 0.59 | 41.71 |
| Financial assets | ||
| – Investments | 3,893.68 | 3,655.08 |
| – Loans | 1,436.30 | 1,568.59 |
| – Other financial assets | 1,047.92 | 262.95 |
| Deferred tax assets (net) | 43.06 | 140.79 |
| Income-tax assets (net) | 356.40 | 598.61 |
| Other non-current assets | 804.88 | 467.41 |
| Total non-current assets | 37,811.27 | 29,878.33 |
| Current assets | ||
| Inventories | 508.97 | 489.95 |
| Financial assets | ||
| – Trade receivables | 3,868.53 | 2,915.86 |
| – Cash and cash equivalents | 959.08 | 1,900.65 |
| – Bank balances other than cash and cash equivalents | 9,804.50 | 8,627.16 |
| – Loans | 103.55 | 145.87 |
| – Other financial assets | 286.48 | 286.58 |
| Other current assets | 172.31 | 161.45 |
| Total current assets | 15,703.42 | 14,527.52 |
| Total assets | 53,514.69 | 44,405.85 |
| EQUITY AND LIABILITIES | ||
| Equity | ||
| Equity share capital | 537.38 | 537.17 |
| Other equity | 39,588.28 | 34,438.91 |
| Total equity | 40,125.66 | 34,976.08 |
| Liabilities | ||
| Non-current liabilities | ||
| Financial liabilities | ||
| – Borrowings | 4,492.02 | 1,143.09 |
| – Lease liabilities | 2,048.62 | 1,779.01 |
| – Other financial liabilities | – | 477.08 |
| Provisions | 1,085.45 | 633.26 |
| Other non-current liabilities | 451.80 | 209.08 |
| Total non-current liabilities | 8,077.89 | 4,241.52 |
| Current liabilities | ||
| Financial liabilities | ||
| – Borrowings | 87.05 | 261.33 |
| – Lease liabilities | 198.90 | 188.46 |
| – Trade payables | ||
| • Total outstanding dues of micro enterprises and small enterprises | 729.49 | 711.76 |
| • Total outstanding dues of creditors other than micro enterprises and small enterprises | 1,291.41 | 975.06 |
| – Other financial liabilities | 1,198.52 | 1,145.21 |
| Other current liabilities | 1,515.04 | 1,470.88 |
| Provisions | 290.73 | 435.55 |
| Total current liabilities | 5,311.14 | 5,188.25 |
| Total equity and liabilities | 53,514.69 | 44,405.85 |
| Particulars | For the year ended 31 March 2026 | For the year ended 31 March 2025 |
|---|---|---|
| A CASH FLOWS FROM OPERATING ACTIVITIES | ||
| Profit before tax | 6,496.54 | 6,230.47 |
| Adjustments for: | ||
| Exceptional items | (3.77) | 498.96 |
| Depreciation and amortisation expense | 1,709.07 | 1,496.11 |
| Gain on disposal of property, plant and equipments (net) | (0.76) | (2.04) |
| Gain on de-recognition of lease liabilities and right of use assets | – | (0.27) |
| Liabilities written back | (41.69) | (45.50) |
| Grant income (on account of government and other grants) | (551.16) | (160.46) |
| Interest income | (973.62) | (813.12) |
| Unrealised foreign exchange loss/(gain) (net) | 3.96 | (3.67) |
| Finance costs | 410.85 | 333.91 |
| Provision/Bad debts written-off on trade receivables and other financial assets | 95.52 | 189.59 |
| Assets written off | 0.68 | – |
| Employee share based payment expense | 368.57 | 0 |
| (Reversal)/provision for contingencies | (5.23) | 59.26 |
| Operating profit before working capital changes | 7,508.96 | 7,783.24 |
| Movement in working capital: | ||
| Inventories | (19.02) | 63.55 |
| Trade receivables | (1,049.90) | (948.87) |
| Other assets | (59.06) | (105.65) |
| Other liabilities | 57.37 | (153.03) |
| Trade payables | 372.15 | 114.05 |
| Provisions | 7.24 | 130.78 |
| Cash flows from operating activities | 6,817.74 | 6,884.07 |
| Income-tax paid (net) | (1,084.57) | (1,607.41) |
| Net cash flows generated from operating activities (A) | 5,733.17 | 5,276.66 |
| B CASH FLOWS FROM INVESTING ACTIVITIES | ||
| Purchase of property plant and equipments, capital work-in-progress and intangible assets (including capital advances, capital creditors and deferred payment liabilities) | (6,755.57) | (4,276.89) |
| Payment for acquisition of land | (1,403.97) | (1,313.70) |
| Proceeds from disposal of property, plant and equipments | 2.98 | 23.13 |
| Movement in other bank balances and bank deposits (net) | (1,984.66) | (1,199.15) |
| Interest received | 893.28 | 788.14 |
| Investment in subsidiary companies | (240.20) | – |
| Investment in equity shares | – | (39.10) |
| Loan to subsidiaries | – | (450.00) |
| Loans repayment from subsidiaries(net) | 174.62 | 85.54 |
| Net cash used in investing activities (B) | (9,313.52) | (6,382.03) |
| C CASH FLOWS FROM FINANCING ACTIVITIES | ||
| Proceeds from issue of equity share capital (net of share issue expenses) | 0.21 | 0.16 |
| Purchase of treasury shares | (98.24) | – |
| Proceeds from borrowings | – | 1,150.00 |
| Proceeds from non-current borrowings | 3,452.12 | – |
| Repayment of borrowings | – | (1,718.57) |
| Dividend paid (including tax) | (134.40) | – |
| Interest paid on borrowings | (250.30) | (114.96) |
| Payment of interest on lease payments | (213.19) | (168.44) |
| Principal elements of lease liabilities | (117.42) | (93.10) |
| Net cash flows generated from/ (used in) financing activities (C) | 2,638.78 | (944.91) |
| Net decrease in cash and cash equivalents (A+B+C) | (941.57) | (2,050.28) |
| Cash and cash equivalents at the beginning of the year | 1,900.65 | 3,950.93 |
| Cash and cash equivalents at the end of the period | 959.08 | 1,900.65 |
| Particulars | 31 March 2026 | 31 March 2025 |
|---|---|---|
| Balances with banks in current accounts | 342.82 | 591.71 |
| Cheques on hand | 0.07 | 0.34 |
| Cash on hand | 36.19 | 28.60 |
| Bank deposits with original maturity less than three months | 580.00 | 1,280.00 |
| Total cash and cash equivalents | 959.08 | 1,900.65 |
| S. No. | Particulars | Quarter ended 31 March 2026 (Refer note 10) | Quarter ended 31 December 2025 (Unaudited) | Quarter ended 31 March 2025 (Refer note 10) | Year ended 31 March 2026 (Audited) | Year ended 31 March 2025 (Audited) |
|---|---|---|---|---|---|---|
| I | Income | |||||
| Revenue from operations | 11,590.47 | 11,210.94 | 9,312.52 | 44,102.66 | 36,923.45 | |
| II | Other income | 367.42 | 217.35 | 229.25 | 985.94 | 789.47 |
| Total income | 11,957.89 | 11,428.29 | 9,541.77 | 45,088.60 | 37,712.92 | |
| III | Expenses | |||||
| Cost of materials consumed | 2,156.47 | 2,267.15 | 1,914.79 | 8,821.31 | 7,899.60 | |
| Purchases of stock-in-trade | 277.98 | 289.28 | 205.11 | 1,173.00 | 924.61 | |
| Changes in inventories of stock-in-trade | 30.84 | 0.16 | 16.29 | (26.30) | (27.52) | |
| Employee benefits expense | 2,846.97 | 2,806.73 | 2,040.54 | 10,961.08 | 8,245.42 | |
| Finance costs | 267.08 | 215.09 | 150.30 | 791.14 | 652.59 | |
| Depreciation and amortisation expense | 665.18 | 611.88 | 492.54 | 2,225.40 | 1,937.48 | |
| Retainers and consultants fee | 1,869.28 | 1,793.95 | 1,315.92 | 6,579.68 | 4,973.43 | |
| Other expenses | 1,971.30 | 1,880.24 | 1,572.94 | 7,402.91 | 6,135.78 | |
| Total expenses | 10,085.10 | 9,864.48 | 7,708.43 | 37,928. |